Distinct bone marrow immunophenotypic features define the splicing factor 3B subunit 1 (SF3B1)‐mutant myelodysplastic syndromes subtype

Splicing factor 3B subunit 1 (SF3B1) mutations define a distinct myelodysplastic syndromes (MDS) patient group with a relatively favourable disease course and high response rates to luspatercept. Few data are available on bone marrow phenotype beyond ring sideroblasts in this subgroup of patients wi...

Full description

Saved in:
Bibliographic Details
Published in:Br J Haematol
Main Authors: Duetz, Carolien, Westers, Theresia M., in ’t Hout, Florentien E. M., Cremers, Eline M. P., Alhan, Canan, Venniker‐Punt, Bianca, Visser‐Wisselaar, Heleen A., Chitu, Dana A., de Graaf, Aniek O., Smit, Linda, Jansen, Joop H., van de Loosdrecht, Arjan A.
Format: Artigo
Language:Inglês
Published: John Wiley and Sons Inc. 2021
Subjects:
Haematological malignancy ‐ Biology
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC8252736/
https://ncbi.nlm.nih.gov/pubmed/33765355
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bjh.17414
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items